藥物成份

共有 21216 個藥物成份

R1 EA Solution \nenzyme acceptor (microbial) : 0.25 g/l ;anti-valproic acid antibody (mouse monoclonal) : 24 mg/l ; N-(2-Hydroxyethyl) piperazine-N-(2-ethanesulfonic) (HEPES) acid buffer ; bovine serum albumin ; sodium salicylate ; buffer salts ; stabilizers ; preservative. \nR2 ED Solution \nenzyme donor (microbial)-valproic acid conjugate : 40 μg/l ; chlorophenol red-β-D-galactopyranoside : 2.4 g/l ; goat anti-mouse antibodies : 27 ml/l ; N-(2-Hydroxyethyl) piperazine-N-(2-ethane-sulfonic) (HEPES) acid buffer ; buffer salts ; stabilizers ; preservative.\n\n

• 關聯藥證數量: 1

R1 EA Working Solution\nR2 ED Working Solution

• 關聯藥證數量: 1

R1 EA working solution\nanti-carbamazepine antibody (mouse monoclonal): 49 mg/L; enzyme acceptor (microbial): 0.171 g/L; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer; stabilizer; buffer salts; preservative

• 關聯藥證數量: 1

R1 ED working solution\nenzyme donor (microbial)-phenobarbital: 38 μg/L; chlorophenol red-β-D-galactopyranoside: 1.64 g/L; anti-phenobarbital antibody (mouse monoclonal): 16.1 mg/L; 3-(N-morpholino)propanesulfonic acid (MOPS) buffer; buffer salts; preservative

• 關聯藥證數量: 1

R1 EDTA: 150 mmol/L.\nR2 Sulfanilic acid: 29 mmol/L; hydrochloric acid: 170 mmol/L\nR2a Sodium nitrite: 25 mmol/L

• 關聯藥證數量: 1

R1 Enzyme reagent\n Tobramycin labeled with bacterial G6PDH in buffer\nR2 Antibody/substrate reagent \n Anti-tobramycin antibody (sheep polyclonal), G6P\n , NAD and bovine serum albumin in buffer

• 關聯藥證數量: 1

R1 Enzyme reagent\n Vancomycin labeled with bacterial G6PDH in buffer\nR2 Antibody/substrate reagent\n Anti-vancomycin antibody (mouse monoclonal)\n , G6P and NAD in buffer

• 關聯藥證數量: 1

R1 Enzyme:\nTris buffer 100mmol/l, pH7.5\nL-alanine 0.5mol/l\nLD >1.2U/ml\nR2 α-oxoglutarate/Conezyme\na-oxoglutarate 15 mmol/l\nNADH 0.8mmol/l

• 關聯藥證數量: 1

R1 Gentamicin conjugate; piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer, pH 7.2; preservative\nR2 Anti-gentamicin antibody (mouse monocloanl); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer, pH 7.5; stabilizer; preservative

• 關聯藥證數量: 1

R1 Glycine buffer 170 mmol/l, pH 8.3; polyethylene glycol 0.05% bovine serm albumin; preservatives and stabilizers.\nR2 Latex particles coated with human IgG

• 關聯藥證數量: 1

R1 HEPES: 52.4 mmol/L; Sodium chloride: 87 mmol/L; Calcium chloride: 0.08 mmol/L; Magnesium chloride: 12.6 mmol/L; α-Glucosidase (microbial): ≥66.8 μkat/L; pH 7.0 (37°C); preservatives; stabilizers\nSR HEPES: 52.4 mmol/L; Ethylidene-G7-PNP: 22 mmol/L; pH 7.0 (37°C); preservatives; stabilizers

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37 °C); EDTA:\n 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP:\n 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP\n (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK\n (yeast): ≥ 36.7 μkat/L (25 °C); G6P-DH (E. coli): ≥ 23.4 μkat/L\n (25 °C); preservative; stabilizer; additive.\nR3 CAPSO* buffer: 20 mmol/L, pH 8.8 (37 °C); glucose:\n 120 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate:\n 184 mmol/L; 4 monoclonal anti-CK-M antibodies (mouse),\n inhibiting capacity: > 99.6 % up to 66.8 μkat/L (4000 U/L) (37 °C)\n CK-M subunit; preservative; stabilizer; additive.\n

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; preservative; stabilizer.

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH 6.0; N-acetylcysteine: 40.0 mmol/L; EDTA:\n 3.0 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0 μmol/L;\n NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; stabilizer\nR2 EDTA: 3.0 mmol/L, pH 9.1; HK (yeast): ≥ 600 μkat/L; G6PDH\n (microbial): ≥ 600 μkat/L; ADP: 12.0 mmol/L; creatine phosphate:\n 180 mmol/L; N-methyldiethanolamine: 69.0 mmol/L; monoclonal murine\n antibodies inhibiting human CK-M (inhibiting capacity ≥ 2000 U/L of\n CK-MM); preservative; stabilizer; detergent

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH: 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0 μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; stabilizer.

• 關聯藥證數量: 1

R1 Intrinsic factor~Ru(bpy)2+ 3 (gray cap), 1 bottle, 10 mL:Ruthenium labeled porcine intrinsic factor 4 μg/L; cobinamide dicyanide 15 μg/L; stabilizer; human serum albumin; phosphate buffer, pH 5.5; preservative.

• 關聯藥證數量: 1

R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≧4.5 mmol/L; NADP:≧7.0 mmol/L; preservative\nR2 HEPES buffer: 200 mmol/L; pH 8.0; Mg2+: 4 mmol/L; HK (yeast):≧300 μkat/L; G-6-PDH (E.coli):≧300 μkat/L; preservative

• 關聯藥證數量: 1

R1 MOPS(3-morpholinopropane sulfonic acid buffer):20.1 mmol/L,pH6.5;HSDA:0.96 mmol/L;ascorbate oxidase(Eupenicillium spec.,recombinant);≧50μkat/L;peroxidase(horseradish): ≧167μkat/L;preservativeR2 MOPS(3-morpholinopropane sulfonic acid buffer):20.1 mmol/L, pH6.8;MGSO4．7H2O:8.11 mmol/L;4-aminoantipyrine:2.46mmol/L;cholesterol esterase(Pseudomonas spec.): ≧50μkat/L;cholesteroloxidASE(Brevibacterium spec., recombinant): ≧33.3μkat/L;peroxidase(horseradish) ≧333μkat/L;detergent;preservative

• 關聯藥證數量: 1

R1 Microplate: 12 strips of 8 wells coated with monoclonal antibodies to p24 HIV1 (mouse) and purified HIV1 and HIV2 antigens\nR2 Concentrated washing solution (20X): Tris NaCl buffer pH 7.4, ProClin 300 0.04%\nR3 Negative control: Heat inactivated human plasma negative for HBs antigen, HIV antigen, anti-HIV1, anti-HIV2 and anti-HCV antibodies, Sodium azide < 0.1%\nR4 HIV Ab positive control: Heat inactivated human plasma positive for anti-HIV antibodies, negative for HIV and HBs antigens and anti-HCV antibodies, in synthetic diluent, ProClin 300 < 0.1%\nR5 HIV Ag positive control: Purified HIV1 antigen inactivated with a chaotropic agent, in synthetic diluent, ProClin 300 < 0.1%\nR6 Conjugate 1: biotinylated polyclonal antibodies to p24 HIV1 (sheep), ProClin 300 0.5%\nR7a Conjugate 2: Lyophilised peroxidase labelled Streptavidin and purified HIV1 and HIV2 antigens\nR7b Conjugate 2 Diluent: kimmed milk solution, ProClin 300 0.5%

• 關聯藥證數量: 1

R1 N-methylglucamine：400 mmol/l, pH 9.4 (37℃);lithium lactate：61 mmol/l R2： NAD：60 mmol/l; stabilizers and preservatives

• 關聯藥證數量: 1

R1 NADH\n NADH 0.18 mmol/l\nR2 Pyruvate 0.6 mmol/l\n Phosphate buffer 17mmol/l, pH7.5\n

• 關聯藥證數量: 1

R1 NBT Reagent/buffer (bottles 1 and 1a) \nNitrotetrazolium-blue: 0.57 mmol/L; sodium cholate: 4.9mmol/L; potassium chloride: 49 mmol/L; potassium phosphate buffer: 49 mmol/L, potassium carbonate buffer: 250 mmol/L, pH 10.3; uricase: &#8805;2.8 kU/L (Arthrobacter species); detergent: 2.1%

• 關聯藥證數量: 1

R1 NaCl 9 %\nR3 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L;\nNADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean): &#8805; 300 μkat/L;\nGLDH (bovine liver): &#8805; 80 μkat/L; preservative; nonreactive stabilizers

• 關聯藥證數量: 1

R1 Nitroblue tetrazolium: 1.2 mmol/L; uricase (microbial):&#8805;12 μkat/L; pH7.5 non-reactive buffer; stabilizer; surfactants\nR3 Carbonate buffer: 1.5 mol/L; pH10.4\n

• 關聯藥證數量: 1

R1 Non-reactive surfactants and stabilizer at an acidic pH.\nR2 4mM Ferenes, 480mM ascorbic acid and non-reactive stabilizers.

• 關聯藥證數量: 1

R1 Oxalate Crystal violet solution;\nR2 Stabilized Lugol-PVP;\nR3 Decolorizer;\nR4 Safranin solution

• 關聯藥證數量: 1

R1 Phenytoin conjugate; Piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer pH 7.3.\nR2 Anti-phenytoin antibody (mouse monoclonal) ; latex microparticle 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.4.

• 關聯藥證數量: 1

R1 Phenytoin conjugated; piperazine-N,N’-bis (ethanesulfonic acid) (PIPES) buffer, pH 7.3; stabilizer; preservative\nR2 Anti-phenytoin antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer, pH 7.4; stabilizer; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/L, pH 7.2; NaCl: 130 mmol/L; PEG: 40g/L; preservative in vial A (liquid).\nR2=SR Anti-human haptoglobin antibody (rabbit)>1.1g/L; NaCl: 100 mmol/L; preservative in vial C (liquid).

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/L, pH 7.2; sodium chloride:0.13 mol/L; PEG: 40 g/L; preservativeR2 Anti-human haptoglobin antibodies (rabbit): >1.1 g/L;NaCl: 0.10 mol/L; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 60mmol/L, pH 7.5; NaCl 100 mmol/L;\nEDTA: 1.0mmol/L; PEG: 3%; preservative\nR2 Anti-human lipoprotein (a) antibodies (rabbit): dependent on\ntiter; NaCl: 100 mmol/L; stabilizer; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer：12.7 mmol/l, pH 7.2;NaCl：0.13 mol/l; PEG：60g/l; preservative R2 Anti-human prealbumin antibody(rabbit)：>0.55 g/l;NaCl：0.10 mol/l;preservative

• 關聯藥證數量: 1

R1 Phosphate buffer：60.7 mmol/L, pH 7.7; 5,5'-dithiobisnitrobenzoic acid：0.3 mmol/L; preservative R2 Butyrylthiocholine iodide：42.5 mmol/L; preservative

• 關聯藥證數量: 1

R1 Phosphoenolpyruvate: >60 mmol/L; NADH analog: 3 mmol/L; MDH (porcine):≧1200 nkat/L; PEPC (microbial):≧120 nkat/L

• 關聯藥證數量: 1

R1 Phosphoenolpyruvate：≧40 mmol/L；NADH analog：≧2.0 mmol/L；MDH (porcine)：≧314.3 μkat；PEPC (microbial)：≧30.8 μkat

• 關聯藥證數量: 1

R1 Potassium hydroxide: 900 mmol/L; Phosphate: 135 mmol/L; pH: ≧13.5; preservative; stabilizer.\nSR Picric acid: 38.2 mmol/L; pH: 6.5; preservative; stabilizer.

• 關聯藥證數量: 1

R1 Sodium hydroxide: 530 mmol/L; EDTA-Na: 74 mmol/LR2 Benzethonium chloride: 32 mmol/L

• 關聯藥證數量: 1

R1 Stabilizing Solution\nR-2 Latex Solution\n Latex coated with anti-AFP polyclonal antibody

• 關聯藥證數量: 1

R1 Sulfamic (H3NO3S): 110 mmol/L; sodium acetate buffer (C2H3NaO2): 85 mmol/L; surfactant; solubilizer\nR2=SR Diazonium ion: 3 mmol/L; HCl: 100 mmol/L

• 關聯藥證數量: 1

R1 Sulfanilic acid in vial A (liquid): Sulfanilic acid 35 mmol/L, Oxalic acid 40 mmol/L, HEDTA 4 mmol/L, Myristyltrimethyl-ammonium bromide 2 %, Dodecyltrimethyl-ammonium bromide 5 %, pH 1.1.\nR2 Nitrite in vial B (liquid): Sodium nitrite 24.5 mmol/L, pH 6.8.

• 關聯藥證數量: 1

R1 Sulfanilic acid: 35 mmol/L; HEDTA: 4.0 mmol/L; oxalic acid: 40 mmol/L; pH 1.2\nR2 Sodium nitrite: 3.9 mmol/L; pH 6.0

• 關聯藥證數量: 1

R1 TES/HCl buffer: 20 mmol/L, pH 7.7; NaCl: 500 mmol/L; preservative\nR2 Latex particles coated with monoclonal anti-human sTfR antibody (mouse); TRIS/HCl buffer: 20 mmol/L, pH 8.0; preservative

• 關聯藥證數量: 1

R1 TRIS (hydroxymethyl)-aminomethane buffer: 16 mmol/L\nR2 Latex particles coated with anti-CRP mouse monoclonal antibodies: 0.1%; glycine buffer: 50 mmol/L

• 關聯藥證數量: 1

R1 TRIS buffer 20 mmol/L, pH8.0; NaCl:200 mmol/L; polyethylene glycol:3.6%; preservative; stabilizers\nR2 Anti-human IgA antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0 NaCl: 150 mmol/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer with bovine serum albumin and immunoglobulins (mouse); preservative; stabilizers\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; preservative; stabilizers

• 關聯藥證數量: 1

R1 TRIS buffer with bovine serum albumin; preservatives.\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; immunoglobulins (mouse); preservative.

• 關聯藥證數量: 1

R1 TRIS buffer, PEG, EDTA, and preservative.\nR2 Polyclonal anti-human albumin antibodies, TRIS buffer, preservative.

• 關聯藥證數量: 1

R1 TRIS buffer, pH 7.5; immunoglobulins (rabbit); preservative, stabilizers\nR3 Aqueous matrix containing latex particles coated with anti-human ferritin antibodies (rabbit); preservative, stabilizers

• 關聯藥證數量: 1

R1 TRIS buffer: 100 mmol/L, pH 7.8; Mg2+: 4 mmol/L; ATP: ≧1.7 mmol/L; NADP : ≧1.0 mmol/L; preservative\nSR HEPES buffer: 30 mmol/L, pH 7.0; Mg2+: 4 mmol/L; HK (yeast): ≧130 μkat/L; G-6-PDH (E.coli):≧250 μkat/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol: 3.6%; preservative; stabilizers\nR2 Anti-human IgM antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L; NADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean):≧300 μkat/L; GLDH (bovine liver):≧80 μkat/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 280 mmol/L, pH 7.3; L-alanine: 1400 mmol/L; NADH: 0.53 mmol/L (yeast); LDH ≧ 3.5 U/mL (microorganisms); preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 50 mmol/L, pH 7.4; preservatives; stabilizers.\nR2 Latex particles coated with anti-CRP mouse monoclonal antibodies: 0.1%; glycine buffer: 50 \nmmol/l, pH 8.0; preservative; stabilizer.\n

• 關聯藥證數量: 1

R1 TRIS buffera: 170 mmol/l, pH 8.2R2 Borate buffer: 10 mmol/l, pH 8.2; latex particles coated with streptolysin O: 2 ml/l

• 關聯藥證數量: 1

R1 TRIS* buffer.\nR2 Latex particles coated with polyclonal anti-human ferritin anti-bodies (rabbit).

• 關聯藥證數量: 1

R1 TRIS* buffer：170 mmol/l,pH8.2\nR2 Borate buffer：100 mmol/l,pH8.2; latex particles coated with streptolysin O：2 ml/l

• 關聯藥證數量: 1

R1 TRISa buffer with bovine serum albumin; preservatives\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; immunoglobulins (mouse); preservative

• 關聯藥證數量: 1

R1 Theophylline conjugate; piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer pH 7.2; preservative\nR2 Anti-theophylline antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.5; stabilizer; preservative

• 關聯藥證數量: 1

R1 Triethanolamine buffer：60 mmol/L,pH 8.0；EDTA：3.1 mmol/L；ammonium acetate：124 mmol/L；ADP≧1.36 mmol/L；NADH (yeast)：0.27 mmol/L；LDH(rabbit muscle) ≧45 μakt/L\nR2 Triethanolamine buffer：8.6 mmol/L,pH 7.9；α-ketoglutarate：48 mmol/L\n

• 關聯藥證數量: 1

R1 aqueous buffered matrix, pH 4. 1\n Componen Concentration\nReactive components \nBuffer Citrate buffer 95 mmol/L\nPreservatives Imidazolidinylurea 2.5 mmol/L \n Oxypyrione 9.0 mmol/L\nStabilizers BriJ-35 4.5 ml/L\n Rhodafac LO 529 1 g/L\nIngredient of biological origin(+ indication of source)

• 關聯藥證數量: 1

R1(10x53 mL, 8x93 mL) Surfactants 4.51%\n HCl 8.204g/L\nR2(10x17 mL, 8x28 mL) \n2, 4-dichloroaniline 0.81g/L \nHCl 5.563g/L\nSodium Nitrite 0.345g/L \nSurfactant：2.00%\n \n

• 關聯藥證數量: 1

R1(4x20mL):\nTRIS 100 mmol/L\nPolyethylene Glycol 30 g/L\nSodium Azide 0.1%\nR2(4x8mL):\nAnti-human IgA goat serum 50%\nTRIS 100 mmol/L\nSodium Azide 0.1%

• 關聯藥證數量: 1

R1. Blank Reagent\n Sodium Hydroxide 200 mmol/l\n Na-K-Tartrate 32 mmol/l\n\nR2. Biuret Reagent\n Sodium Hydroxide 200 mmol/l\n Na-K-tartrate 32 mmol/l\n Potassium Iodide 15 mmol/l\n Cupric Sulfate 6 mmol/l

• 關聯藥證數量: 1

R1. Enzyme Reagent\n Hepes buffer 52.5 mmol/l, pH 7.15\n Sodium chloride 87 mmol/l\nMagnesium chloride 12.6 mmol/l\nα-Glucosidase &sup3; 4 U/ml\nR2. Substrate\n 4,6-Ethylidene-G7 pNP 22 mmol/l \n\n

• 關聯藥證數量: 1

R1. Assay Buffer \n Polyethylene Glycol maximun 4%\n Tris/HCl buffer 20 mmol/l, pH.4\n Sodium Chloride 150mmol/l\nR2. Antibody Reagent\n Anti (human) CRP \n \n

• 關聯藥證數量: 1

R1. BCG Reagent: Succinate buffer 75 mmol/l; pH 4.2, Bromocresol green 0.15 mmol/l, Brij 35, Preservative

• 關聯藥證數量: 1

R1. Blank Reagent\n Sulphuric acid 0.36 mol/l\n Sodium chloride \n Detergent 154mmol/l\nR2. Molybdate Reagent\n Ammonium molybdate 3.5mmol/l\n Sulphuric acid 0.36mol/l\n Sodium chloride 154mmol/l

• 關聯藥證數量: 1

R1. Buffer/Glycylglycine/Substrate\n Tris buffer 100 mmol/l, pH 8.25\n Glycylglycine 100 mmol/l\n L-γ-glutamyl-3-carboxy-4-nitroanilide 2.9 mmol/l

• 關聯藥證數量: 1

R1. Buffer\n Glycine Buffer 170 mmol/l, pH 8.3\n Sodium chloride 100 mmol/l\n\nR2. Latex Reagent \n Glycine Buffer 170 mmol/l, pH 7.3\n Sodium chloride 100 mmol/l\n Latex particles coated with Anti-Ferritin 0.07% w/v\nIT 2691: liquid Protein\n

• 關聯藥證數量: 1

R1. Buffer\n Pipes 100 mmol/l, pH 7.6\n ATP 4 mmol/l\n NAD+ 3 mmol/l\n Magnesium ions 15 mmol/l\n Sodium Azide \nR2/2. Enzyme Reagent \n Hexokinase &#8805; 25 U/ml\n G-6-PDH &#8805; 75 U/ml\n Sodium Azide \n

• 關聯藥證數量: 1

R1. Buffer\n Tris Buffer 25 mmol/l, pH 6.5\n \n2. Enzyme Reagent \n Phosphoenolpyruvate (PEP) 6.3 mmol/l\n NADH 1.2 mmol/l\n Phosphoenolpyruvate Carboxylase (PEPC) 200 U/l\n Malate Dehydrogenase (MDH) 600 U/l\n Mg2+ 8.0 mmol/l \n

• 關聯藥證數量: 1

R1. Buffer\n Acetate buffer\n Guanidinium chloride\n Thiourea\nR2. Chromogen\n Ferrozine\n Ascorbic acid

• 關聯藥證數量: 1

R1. Detergent\n Hydrochloric Acid 0.1 mol/L\n Detergent 3%\nR2. DPD Reagent\n Dichlorophenyl diazonium \n compound 6.0 mmol/l\n Hydrochloric Acid 0.1 mol/l \n Detergent 3%\n

• 關聯藥證數量: 1

R1. Enzyme \n Tris buffer 80 mmol/l, pH 7.5\n L-aspartarte 240 mmol/l\n MDH &#8805; 0.42U/ml \n LD &#8805; 0.60U/ml\nR2. α-oxoglutarate/Coenzyme\n α-oxoglutarate 12 mmol/l\n NADH 0.18 mmol/l\n\n

• 關聯藥證數量: 1

R1. Reagent Phosphate Buffer 50 mmol/l, pH 7.0、\n Toos* 7.0 mmol/l、\n Ascorbate Oxidase ≧5 U/ml;\nR2. Starter Phosphate Buffer 50 mmol/l, pH 7.0、\n 4-Aminophenazone 0.3 mmol/l、\n Peroxidase ≧1000 U/l、\n Uricase ≧200 U/l

• 關聯藥證數量: 1

R1.Enzyme Reagent 1:N,N-Bis(2-hydroxyethy)-2-aminoethanesulfonic acid\n N-(2-hydroxy-3-Sulfopropyl)-3,5-dimethoxyaniline;Sodium Salt(HDAOS)\n Cholesterol Esterase\n Cholesterol Oxidase\n Catalase\n Ascorbate oxidase\nR2. Enzyme Reagent 2:N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid\n 4-Aminoantipyrine\n Peroxidase\n Sodium Azide\n Surfactants

• 關聯藥證數量: 1

R10:STOPPING SOLUTION. 1 N SULPHURIC ACID SOLUTION ADHESIVE FILMS

• 關聯藥證數量: 1

R11. Diluent: 2.75 mg/ml ammonium molybdate2. SurfactantR2 Reductant

• 關聯藥證數量: 1

R1: Imidazole pH7.0±0.3 10 mmol/L, Mg2+ 10 mmol/L AMP 5.0 mmol/L, Hexokinase 3000 U/L G6PDH 2500 U/L, Creatine phosphate 30 mmol/LR2: D-glucose 20 mmol/L, ADP 5 mmol/L

• 關聯藥證數量: 1

R1: Tris buffer 100 mmol/L α-KG 5 mmol/L ADP 0.6 mmol/L GLDH >1500 U/L Urease >20 U/LR2: Tris buffer 100 mmol/L NADH 0.25 mmol/L

• 關聯藥證數量: 1

R1: \nMES buffer pH 6.3Detergent 1Ascorbic acid oxidase 4-AminoantipyrinePeroxidase Cholesterol oxidaseCholesterol esteraseProclin 3 U/ml0.67 mmol/l1.25 U/ml1.2 U/ml1.0 U/ml0.05%\nR2: \nMES buffer pH 6.3Detergent 2Sulfobutyl toluidine (DSBmT)Proclin 1 mmol/l0.05%\n

• 關聯藥證數量: 1

R1: Antibody reagent in vial A (liquid)\n Anti-benzodiazepine antibody (sheep polyclonal) in buffer, pH 7.5, with stabilizers and preservative.\nR2: Diluent in vial B (liquid)\n Buffer containing stabilizer and preservative.\nR3=SR: Tracer in vial C (liquid)\n Fluorescein-labeled benzodiazepine derivative in buffer, pH 7.0, with stabilizer and preservative.

• 關聯藥證數量: 1

R1: Antibody/Microparticle Reagent \nMicroparticels attached to morphine antibody (mouse monoclonal) in buffer, bovine serum albumin and 0.09% sodium azide.\nR2: Conjugate Reagent

• 關聯藥證數量: 1

R1: Buffer pH 9.0 240 mmol/l\n Stabilizers and preservatives\nR2: Buffer pH 6.6 8 mmol/l\n NAD >= 2 mmol/l\n Alcohol dehydrogenase (ADH) >= 40 kU/I\n Stabilizers and preservatives \n

• 關聯藥證數量: 1

R1: Polyethylene Glycols 10%、\n Phosphate buffer 100 mmol/L、\n NaCl 200 mmol/L、\nR2: anti-albumin antibody >10 mg/L、\n Phosphate buffer 100 mmol/L、\n NaCl 200 mmol/L

• 關聯藥證數量: 1

R1: Sodium hydroxide: 400mmol/l, potassium sodium tartrate: 89mmol/lR2: Sodium hydroxide: 400mmol/l, potassium sodium tartrate: 89mmol/l;potassium iodide: 61mmol/l; copper sulfate: 24.3mmol/l

• 關聯藥證數量: 1

R1: TRIS 100 mmol/l L-Alanine 500 mmol/l LDH ≧ 1700 U/lR2: 2-Oxyglutarate 15 mmol/l NADH 0.18 mmol/l

• 關聯藥證數量: 1

R1: (Color A) ACS, CoA, ATP, 4-aminoantipyrine, Ascorbate oxidase (AOD),\n(Solvent A) Phosphate buffer\nR2: (Color B) ACOD, Peroxidase (POD)\n (Solvent B) MEHA\nStandard solution: contains oleic acid and stabilizer\n

• 關聯藥證數量: 1

R1: 3x20 mL (TRIS 100 mmol/L、Polyethylene Glycol 40 g/L、Sodium Azide 0.1%。)\nR2: 3x8 mL (Anti-human complement C3 goat serum 35%、TRIS 100 mmol/L、\n Sodium Azide 0.1%。) \n \n

• 關聯藥證數量: 1

R1: 4 x 12.5 mL containing Buffer, Methylisothiazolone (MIT) 0.03% w/v.\nR2: 4 x 4.5 mL containing Latex particles coated with anti-cystatin C, antibody(rabbit), Sodium azide 0.09%.w/v.\nCalibrator: 5 x 2.0 mL containing Recombinant human Cystatin C in human serum (<0.1%), Sodium azide \n

• 關聯藥證數量: 1

R1: 4x20 mL (TRIS 100 mmol/L、Polyethylene Glycol 25 g/L、Sodium Azide 0.1%。)R2: 4x8 mL (Anti-human IgM goat serum 30%、TRIS 100 mmol/L、 Sodium Azide 0.1%。)

• 關聯藥證數量: 1

R1: Acetate buffer pH 4.5 800 mmol/l\n Thiourea 90 mmol/l\nR2: Ascorbic acid 45 mmol/l\n Ferene 0.6 mmol/l\n Thiourea 20 mmol/l

• 關聯藥證數量: 1

R1: Acetic acid buffer (pH=4.3)\nThioglycolic acid 20mmol/L\nHydroxylamine HCl 500mmol/L\nR2: Ferrozine 0.4mmol/L

• 關聯藥證數量: 1

R1: Anti-CKM antibody 1500 U/L, AMP 5 mmol/L, immidazole 10 mmol/L, G6PDH 2500 U/L, creatine phosphate 30 mmol/L, Mg2+ 10 mmol/L, and hexokinase 3000 U/L\nR2: NADP 2 mmol/L, glucose 20 mmol/L, and ADP 5 mmol/L\n

• 關聯藥證數量: 1

R1: Anti-IgA T antiserum (rabbit) specific for human IgA in phosphate buffer.\nR2: IgA in diluted serum (human).

• 關聯藥證數量: 1

R1: Anti-digitoxin monoclonal antibody (mouse).\nR2: Conjugated digitoxin derivative microparticles.

• 關聯藥證數量: 1

R1: Antibody Working Solution\nBenzoylecgonine polyclonal antibody (sheep) in a buffer with bovine serum albumin.\nR2: Microparticle Working Solution\nConjugated benzoylecgonine derivative microparticles in buffer.

• 關聯藥證數量: 1

R1: Buffer (pH8.95)±0.3\nSodium pyruvate 55 mmol/L\nR2: NADH 7.5 mmol/L

• 關聯藥證數量: 1

R1: Buffer Reagent 2 x 20 ml\nTris (hydroxymethyl) aminomethane\nR2: Antiserum Reagent 1 x 8 ml\nAnti-human fibrinogen goat antiserum\nFibrinogen Calibrator (lyophilized) 1 x 1ml\nApproximately 340 mg/dl* (1/21) human Fibrinogen\nExact value is indicated on calibrator vial label.

• 關聯藥證數量: 1

R1: Buffer Reagent\n170mM glycine buffer solution\nR2: Latex suspension\n0.17%(w/v) solution of latex particles\ncoated with rabbit anti-human CRP antibodies\nCalibrator 1-5 Human CRP\nContain pooled human serum with assigned\nValues for the specific serum protein CRP

• 關聯藥證數量: 1